| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-08 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-08 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-08 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-08 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |